Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.42 USD
-0.34 (-2.89%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $11.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
DVAX 11.42 -0.34(-2.89%)
Will DVAX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVAX
Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why
Collegium (COLL) Shares Rise on Financial Outlook for 2024
Other News for DVAX
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Dynavax Appoints Interim CFO During MacDonald’s Leave
Dynavax Technologies: Still A Believer
Dynavax: Holding Firm Despite Its Missing Cash Cow
Dynavax (NASDAQ:DVAX): Potential Growth at a Rich Valuation